Joinn Laboratories(China)Co.,Ltd.
603127
Rang in aandelen
#3812
Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of... Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.
Aandeelprijs
$6.82
Marktkapitalisatie
$4.30B
Verandering (1 dag)
-6.30%
Verandering (1 jaar)
48.79%
Land
CN
Handel Joinn Laboratories(China)Co.,Ltd. (603127)
Categorie
Healthcare
Winst voor Joinn Laboratories(China)Co.,Ltd. (603127)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van Joinn Laboratories(China)Co.,Ltd. bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Joinn Laboratories(China)Co.,Ltd. van 2012 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2025 | $48.24M | 238.43% |
| 2024 | $14.25M | -80.10% |
| 2023 | $71.62M | -60.16% |
| 2022 | $179.77M | 77.97% |
| 2021 | $101.01M | 83.00% |
| 2020 | $55.19M | 78.38% |
| 2019 | $30.94M | 66.47% |
| 2018 | $18.59M | 29.46% |
| 2017 | $14.36M | 63.39% |
| 2016 | $8.79M | -1.08% |
| 2015 | $8.88M | -12.00% |
| 2014 | $10.09M | 132.26% |
| 2013 | $4.35M | 289.26% |
| 2012 | $1.12M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $7.87B | - |
US
|
|
| $4.82B | - |
US
|
|
| $-252.70M | - |
US
|
|
| - | - |
CN
|
|
| $1.66B | - |
US
|
